A Study Comparing Venetoclax + Fulvestrant vs Fulvestrant In Women with Estrogen Receptor Positive, Her2 Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy
A Study Comparing Venetoclax + Fulvestrant vs Fulvestrant In Women with Estrogen Receptor Positive, Her2 Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy
Trial Category:
Breast
Phase
II
Contact(s)
Location(s)
Nebraska Hematology Oncology, Lincoln, NE
